Terry Henry concentrates his practice on product liability and general commercial litigation. His practice is focused on the defense of companies that design and manufacture medical devices, pharmaceuticals, chemicals, and home safety products.
- Terry works with a variety of product manufacturers when there are questions about their products.
- Terry serves as national coordinating and trial counsel for drug and medical device companies, coordinating the defense of litigation that challenges the safety and effectiveness of products across multiple jurisdictions.
- He also consults with his clients on product recalls, compliance with industry standards, limiting or controlling risk, and product manufacturing and distribution in highly regulated industries.
- Terry assists clients in developing product literature, review of quality processes, product failure investigations, and crisis management.
- He regularly leads litigation in commercial cases, representing life sciences companies in contract, labeling, and other proceedings in which an understanding of the life sciences industry is essential.
Terry is a noted writer and speaker. Some of his recent publications and presentations include:
- “Opioid Enforcement and Litigation Landscape” speaker, ACI Drug and Medical Device Conference, New York, NY, November 30, 2018.
- “A Ray of Hope for Innovator Liability,” Drug & Device Law Blog, April 20, 2018.
- “Why Innovator Liability is the Least Scary Thing About Rafferty,” Law360, April 3, 2018.
- “Understanding a Medical Device Manufacturer’s Broad Duty to Warn”, co-authored with Lauren O’Donnell, Melanie Carter and Naomi Zwillenberg, Medical Device and Diagnostic Industry, Regulatory and Compliance, April 13, 2017.
- “Understanding Defense Strategies for 505(b)(2) Drugs,” co-authored with Ann E. Querns, Law360, March 24, 2017.
- “Practical Tips for Taking the Deposition of an Adversary’s Expert Witness” presentation at the Women in Products Liability CLE Program, ABA Section of Litigation, November 3, 2016.
- “Protecting the Company; Checklist for When Your Company Gets Sued” presentation to Association of Corporate Counsel of Greater Philadelphia, June 3, 2015.
- “The Use of Social Media in Life Sciences,” White Paper co-authored with Lauren Tulli, January, 2011.
- “Corporate Officers Beware: Recent FDA Guidelines Provide Clarification for Park Prosecutions Against Individual Executives,” co-authored with Lauren A. Tulli, Impact Times (Vol.1 No. 4), March 11, 2011.
- “Preemption is Not Dead – A Fresh Look at Wyeth v. Levine in Context,” White Paper co-authored with Lauren Tulli and Scott Reid, March 4, 2009.
- “Smoothing the Wrinkles of Off-Label Promotion – Allergan’s Preemptive Strike against the FDA,” White Paper co-authored with Lauren Tulli, November, 2010.
Outside the Firm
Mr. Henry is a board member of the Kind Human Foundation, a charitable organization focused on providing those in developing countries access to clean drinking water. He also provides legal assistance to the Philadelphia Outward Bound School and Philly Goat Project, two not-for-profit organizations focused on helping people and improving communities.
Mr. Henry previously served as president of the Overbrook Farms Club, a district within the City of Philadelphia listed on the National Registry of Historic Places. He also served as president of the Overbrook Farms Civic Association, a 501(c)(3) community development corporation focused on preserving the historic nature of the neighborhood, encouraging family and community building activities, and maintaining the quality of life. Mr. Henry is a recent past president of the Overbrook Presbyterian Church Corporation.
From 1984 to 1992, Mr. Henry was a Commissioned Officer (Captain) with the United States Army. He is the recipient of a Bronze Star and Meritorious Service Medal.